Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLID.L Regulatory News (LID)

  • There is currently no data for LID

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Master distribution agreement

23 Nov 2015 07:00

RNS Number : 5173G
LiDCO Group Plc
23 November 2015
 

 

LIDCO GROUP PLC

("LiDCO" or the "Company" or "the Group")

 

Master distribution agreement

 

LiDCO (AIM: LID), the hemodynamic monitoring company, announces that it has signed a master distribution agreement for all of LiDCO products with Fieldman Medical for selected territories across the Asia Pacific area.

 

The agreement is an initial two year contract to actively promote the LiDCO product range and covers selected markets in South East Asia & Australasia, namely: the Republic of Korea, Taiwan, Australia, New Zealand, Thailand, Philippines, Indonesia, and Vietnam. Fieldman Medical will take responsibility for distributor management in those territories as well as the co-ordination of the regulatory, registration, and competitive activities.

 

Fieldman Medical has developed a partner ecosystem that strives to improve healthcare for all the people of the Asia Pacific region by bringing the latest and most advanced developments in healthcare to the region. This is a particularly powerful offering for small to medium sized companies with excellent clinical product but with limited resources to address global markets.

 

Commenting Matt Sassone, Chief Executive Officer, said:

"As with the MedAssets deal announced recently this is another example of our creative approach to making our products available globally.

 

"The agreement with Fieldman Medical in Asia creates a significant opportunity to improve people's lives across Asia Pacific by making our hemodynamic monitoring solutions available during surgical procedures. Fieldman's approach creates an opportunity for us as a developer and manufacturer of innovative devices, to expand availability of our products worldwide without significantly increasing our cost base. It also allows us to overcome the challenges of addressing the complexities of culture, language, accessibility and regulation across many countries."

 

 

 

LiDCO Group Plc

www.lidco.com

Matt Sassone (CEO)

Tel: +44 (0)20 7749 1500

Paul Clifford (Finance Director)

 

 

 

finnCap

Tel: +44 (0)20 7600 1658

Geoff Nash / Emily Watts (Corporate Finance)

 

Stephen Norcross (Corporate Broking)

 

 

 

Walbrook PR Ltd

Tel: 020 7933 8780 or lidco@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07584 391 303

 

 

 

About LiDCO Group Plc (www.lidco.com)

LiDCO is a supplier of non-invasive and minimally invasive hemodynamic equipment to hospitals used to monitor the amount of blood flowing around the body and ensure that vital organs are adequately oxygenated. LiDCO's products facilitate the application of hemodynamic optimisation protocols for high risk patients in both critical care units and in the operating theatre. 

 

Increasingly clinical studies are showing that the optimisation of patients' hemodynamic status in high risk patients produces better outcomes and reduced hospital stay. LiDCO's computer-based technology, developed at St Thomas' Hospital in London, has been shown to significantly reduce morbidity and complications, length of stay and overall costs associated with major surgery.

 

Key Products:

 

LiDCOplus: a computer-based platform monitor used in the Intensive Care Unit for real-time continuous display of hemodynamic parameters including cardiac output, oxygen delivery and fluid-volume responsiveness (PPV% and SVV%).

 

LiDCOrapid: a cardiac output monitor designed specifically for use in the operating theatre for fluid and drug management. The monitor enables anaesthetists to receive accurate and immediate feedback on the patient's fluid and hemodynamic status - a key measure of overall well-being before, during and after surgery. The LiDCOrapid provides:

 

· early and rapid warning of hemodynamic change to aid choice of therapeutic route: fluid or drug

· quantification of hemodynamic response

· guidance on effective delivery of fluids to ensure the right amount at the right time

 

LiDCOview: an easy-to-use graphical display of historical LiDCOplus and LiDCOrapid hemodynamic data.

 

LiDCO Unity Software: software incorporated into LiDCOrapid v2 that allows the LiDCOrapid monitor to co-display Covidien's level of consciousness parameter ('BISTM')* and add the convenience of CNSystem's continuous non-invasive blood pressure monitoring ('CNAP')**. This will address a growing requirement for non-invasive monitoring solutions that are more comprehensive and can effectively replace multiple single parameter monitors. 

 

*BISTM and Bispectral Index are trademarks of Covidien LP registered in the US and foreign countries.

**CNAPTM is a trademark of CNSystems Medizintechnik AG.

 

LiDCO monitors use single-patient disposables (sensors or smartcards) which provide an ongoing revenue stream.

 

LiDCO Distribution Network:

LiDCO sells directly to hospitals in the UK and USA and through a network of specialty critical care and anaesthesia distributors in the rest of the world.

 

LiDCO's marketing office is in Cambridge, its manufacturing facility and headquarters are in London and its shares are traded on AIM.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFLRLRLIFIE
Date   Source Headline
30th Dec 20209:35 amRNSHolding(s) in Company
22nd Dec 20202:26 pmRNSCommencement of Compulsory Purchase
16th Dec 20203:58 pmRNSDirector/PDMR Shareholding
10th Dec 20206:11 pmRNSDirector/PDMR Shareholdings
8th Dec 20206:02 pmRNSNotice of Cancellation
8th Dec 20205:30 pmRNSLiDCO Group
8th Dec 20207:00 amRNSOffer declared unconditional in all respects
7th Dec 202010:57 amRNSForm 8.5 (EPT/RI)
4th Dec 202010:12 amRNSForm 8.5 (EPT/RI)
3rd Dec 202012:02 pmRNSForm 8.5 (EPT/RI)
3rd Dec 20209:17 amRNSForm 8.3 - LiDCO Group Plc
2nd Dec 202012:01 pmRNSForm 8.5 (EPT/RI)
2nd Dec 20208:40 amRNSForm 8.3 - LiDCO Group Plc
1st Dec 202010:43 amRNSForm 8.5 (EPT/RI)
30th Nov 202011:58 amRNSForm 8.5 (EPT/RI)
27th Nov 202010:01 amRNSForm 8.5 (EPT/RI)
26th Nov 202012:20 pmRNSBlock Listing Update
26th Nov 202011:58 amRNSForm 8.5 (EPT/RI)
25th Nov 20203:33 pmRNSForm 8.3 - LiDCO Group Plc
25th Nov 20201:05 pmRNSHolding(s) in Company
25th Nov 20209:09 amRNSForm 8.5 (EPT/RI)
25th Nov 20208:50 amRNSForm 8.3 - [LIDCO GROUP PLC]
25th Nov 20207:00 amRNSForm 8 (DD) - Masimo LHC Ltd / LiDCO Group Plc
25th Nov 20207:00 amRNSForm 8.3 - Lidco Group PLC
24th Nov 202010:01 amRNSForm 8.5 (EPT/RI)
24th Nov 20207:00 amRNSFirst closing and extension of Offer
23rd Nov 20205:40 pmRNSForm 8.3 - LiDCO Group Plc
23rd Nov 20204:53 pmRNSHolding(s) in Company
23rd Nov 20207:00 amRNSForm 8 (DD) - Masimo LHC Ltd / LiDCO Group Plc
19th Nov 202011:44 amRNSForm 8.5 (EPT/RI)
19th Nov 20207:00 amRNSForm 8 (DD) - Masimo LHC Ltd / LiDCO Group Plc
18th Nov 202010:08 amRNSForm 8.5 (EPT/RI)
17th Nov 20206:33 pmRNSForm 8.3 - LIDCO PLC GROUP
17th Nov 20204:50 pmRNSForm 8.3 - LiDCO Group Plc
17th Nov 20202:10 pmRNSForm 8.3 - LiDCO Group Plc
17th Nov 202011:36 amRNSForm 8.5 (EPT/RI)
17th Nov 202010:54 amRNSForm 8 (DD) - Masimo LHC Ltd / LiDCO Group Plc
17th Nov 20208:56 amRNSForm 8.3 - LIDCO GROUP PLC
16th Nov 20206:36 pmRNSForm 8.3 - LIDCO GROUP
16th Nov 20205:07 pmRNSForm 8 (OPD) LIDCO GROUP PLC
16th Nov 202010:33 amRNSForm 8.5 (EPT/RI)
16th Nov 20207:33 amRNSForm 8.3 - [LIDCO GROUP PLC]
13th Nov 20204:36 pmRNSForm 8.3 - LiDCO Group Plc
13th Nov 20204:00 pmRNSForm 8.3 - LiDCO Group Plc
13th Nov 202011:10 amRNSForm 8.5 (EPT/RI)
12th Nov 202011:28 amRNSForm 8.5 (EPT/RI)
12th Nov 20208:53 amRNSForm 8.3 - LIDCO Group Plc
12th Nov 20207:00 amRNSForm 8 (DD) - Masimo LHC Ltd / LiDCO Group Plc
11th Nov 202011:36 amRNSForm 8.5 (EPT/RI)
10th Nov 202011:35 amRNSForm 8.5 (EPT/RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.